SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?


To: Chuck Rubin who wrote (1169)6/26/1998 1:10:00 AM
From: BIGFRED  Read Replies (4) | Respond to of 4650
 
Hi Chuck:

In the past few weeks I saw a lot of new names on this thread and I would like to welcome all of you. As a shareholder, I was very excited when I learned that the Biomoda test cancer kit is 1 year ahead of schedule and for only 10 dollars per kit. But I was also disappointed to find out that we needed about 6 more months for the delivery of the Bill Boards.

Adot needs the Bill Boards because that is how the EPS will come.
If there is a CPA reading this post, please confirm what I am going to say. Biomoda will increase ADOT's assets and will not be included in the EPS since it is not a subsidiary.Can any CPA confirm that?

Also, please disregard Brad's latest revenue and EPS projections for 1998. Since the BB are behind schedule and we don't know the extent of the shares buy back, it is futile to estimate revenue and EPS until the BB are delivered.

As always, thank you John for your efforts and for taking the time to share these 10 part series with us.

Take care

Fred